Cargando…

Effectiveness of lipid-lowering therapy on mortality and major adverse cardiovascular event outcomes in patients undergoing percutaneous coronary intervention: a network meta-analysis of randomised controlled trials

BACKGROUND: Emergency percutaneous coronary intervention (PCI) can quickly restore myocardial perfusion after acute coronary syndrome. Whether and which lipid-lowering regimens are effective in reducing major adverse cardiovascular events (MACEs) and mortality risk after PCI remain unclear. OBJECTIV...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deng, Chang-Jiang, Yan, Ju, Zheng, Ying-Ying, Wu, Ting-Ting, Pan, Ying, Hou, Xian-Geng, Wang, Si-Fan, Sirajidin, Subinur, Aimaitijiang, Mikereyi, Xie, Xiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660972/ https://www.ncbi.nlm.nih.gov/pubmed/37967998 http://dx.doi.org/10.1136/bmjopen-2022-070827

Ejemplares similares

Estimation of Major Adverse Cardiovascular Events in Patients With Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Risk Prediction Score Model From a Derivation and Validation Study
por: Zhao, Xiaoxiao, et al.
Publicado: (2020)

Rate pressure product as a novel predictor of long-term adverse outcomes in patients after percutaneous coronary intervention: a retrospective cohort study
por: Jiang, Zhi-Hui, et al.
Publicado: (2023)

Lower Plasma Elabela Levels in Hypertensive Patients With Heart Failure Predict the Occurrence of Major Adverse Cardiac Events: A Preliminary Study
por: Ma, Zheng, et al.
Publicado: (2021)

Hemoglobin-to-Red-Cell Distribution Width Ratio Is a Novel Predictor of Long-Term Patient Outcomes After Percutaneous Coronary Intervention: A Retrospective Cohort Study
por: Xiu, Wen-Juan, et al.
Publicado: (2022)

ALB-dNLR Score Predicts Mortality in Coronary Artery Disease Patients After Percutaneous Coronary Intervention
por: Xiu, Wen-Juan, et al.
Publicado: (2022)

Neurotensin and Adverse Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Intervention
por: Tscharre, Maximilian, et al.
Publicado: (2022)

Effects of intensive lipid lowering compared with moderate-intensity lipid lowering on coronary atherosclerotic plaque phenotype and major adverse cardiovascular events in adults with low to intermediate 10-year ASCVD risk (ILLUMINATION study): protocol for a multicentre, open-label, blinded-endpoint, randomised controlled trial
por: Zheng, Jianan, et al.
Publicado: (2023)

White Blood Cell Counts to High-Density Lipoprotein Cholesterol Ratio, as a Novel Predictor of Long-Term Adverse Outcomes in Patients After Percutaneous Coronary Intervention: A Retrospective Cohort Study
por: Wu, Ting-Ting, et al.
Publicado: (2021)

Prediction of 2-Year Major Adverse Limb Event-Free Survival After Percutaneous Transluminal Angioplasty and Stenting for Lower Limb Atherosclerosis Obliterans: A Machine Learning-Based Study
por: Pan, Tianyue, et al.
Publicado: (2022)

Novel Insight Into Long-Term Risk of Major Adverse Cardiovascular and Cerebrovascular Events Following Lower Extremity Arteriosclerosis Obliterans
por: Sun, Ji, et al.
Publicado: (2022)

The Usefulness of C-Reactive Protein to Albumin Ratio in the Prediction of Adverse Cardiovascular Events in Coronary Chronic Total Occlusion Undergoing Percutaneous Coronary Intervention
por: Cheng, Lele, et al.
Publicado: (2021)

Comparison of conventional scoring systems to machine learning models for the prediction of major adverse cardiovascular events in patients undergoing coronary computed tomography angiography
por: Ghorashi, Seyyed Mojtaba, et al.
Publicado: (2022)

The role of clopidogrel resistance-related genetic and epigenetic factors in major adverse cardiovascular events among patients with acute coronary syndrome after percutaneous coronary intervention
por: Giantini, Astuti, et al.
Publicado: (2023)

Red blood cell distribution width as long-term prognostic markers in patients with coronary artery disease undergoing percutaneous coronary intervention
por: Wu, Ting-Ting, et al.
Publicado: (2019)

Screening of Lipid Metabolism-Related Gene Diagnostic Signature for Patients With Dilated Cardiomyopathy
por: Xu, Man, et al.
Publicado: (2022)

Monocyte-to-albumin ratio as a novel predictor of long-term adverse outcomes in patients after percutaneous coronary intervention
por: Zhang, Zeng-Lei, et al.
Publicado: (2021)

Grade 3 Echocardiographic Diastolic Dysfunction Is Associated With Increased Risk of Major Adverse Cardiovascular Events After Surgery: A Retrospective Cohort Study
por: Zhou, Yan, et al.
Publicado: (2019)

Risk of Major Adverse Cardiovascular Events and Major Hemorrhage Among White and Black Patients Undergoing Percutaneous Coronary Intervention
por: Cai, Anping, et al.
Publicado: (2019)

microRNAs as biomarkers of risk of major adverse cardiovascular events in atrial fibrillation
por: de los Reyes-García, Ascensión M., et al.
Publicado: (2023)

Lipid‐lowering treatment patterns in patients with new cardiovascular events – estimates from population‐based register data in Sweden
por: Hallberg, S., et al.
Publicado: (2016)

Impact of premature coronary artery disease on adverse event risk following first percutaneous coronary intervention
por: Pinxterhuis, Tineke H., et al.
Publicado: (2023)

Contrast-Induced Acute Kidney Injury in Patients on SGLT2 Inhibitors Undergoing Percutaneous Coronary Interventions: A Propensity-Matched Analysis
por: Hua, Rui, et al.
Publicado: (2022)

Prediabetes as a risk factor for major adverse cardiovascular events
por: Mando, Ramy, et al.
Publicado: (2021)

Construction and evaluation of nomogram model for individualized prediction of risk of major adverse cardiovascular events during hospitalization after percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction
por: Fang, Caoyang, et al.
Publicado: (2022)

Clinical Characteristics and Long-Term Outcomes of Patients With Differing Haemoglobin Levels Undergoing Semi-Urgent and Elective Percutaneous Coronary Intervention in an Asian Population
por: Soh, Rodney Yu-Hang, et al.
Publicado: (2022)

Impact of lipid-lowering therapy on the prevalence of dyslipidaemia in patients at high-risk of cardiovascular events in UK primary care – a retrospective database study
por: Jameson, K, et al.
Publicado: (2013)

Baseline white blood cell count-to-apolipoprotein A1 ratio as a novel predictor of long-term adverse outcomes in patients who underwent percutaneous coronary intervention: a retrospective cohort study
por: Pan, Ying, et al.
Publicado: (2020)

The influence of testosterone on the risk of cardiovascular events after percutaneous coronary intervention
por: Chiang, Cheng-Hung, et al.
Publicado: (2022)

Hypothyroidism predicts worsened prognosis in patients undergoing percutaneous coronary intervention
por: Cohen, Ben, et al.
Publicado: (2022)

Serum copper levels and risk of major adverse cardiovascular events: a systematic review and meta-analysis
por: Muñoz-Bravo, Carlos, et al.
Publicado: (2023)

Efficacy and safety of high-dose Xueshuantong injection (lyophilised) in reducing the incidence of major adverse cardiovascular events in patients with unstable angina: a protocol of a randomised, parallel-arm, controlled, double-blind and multicentre clinical trial based on dual antiplatelet therapy
por: Long, Wenjie, et al.
Publicado: (2020)

One-year major adverse cardiovascular events among same-day discharged patients after primary percutaneous coronary intervention at a tertiary care cardiac centre in Karachi, Pakistan: a prospective observational study
por: Shah, Jehangir Ali, et al.
Publicado: (2023)

Risk factors for target vessel endoleaks after physician-modified fenestrated or branched endovascular aortic arch repair: A retrospective study
por: Chen, Zhipeng, et al.
Publicado: (2023)

Adjustment of the GRACE Risk Score by Monocyte to High-Density Lipoprotein Ratio Improves Prediction of Adverse Cardiovascular Outcomes in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
por: Ma, Xiaoteng, et al.
Publicado: (2022)

Application of continuous nursing care based on hierarchical diagnosis and treatment mode in Stage II cardiac rehabilitation of patients after percutaneous coronary intervention
por: Dai, Zhen-Juan, et al.
Publicado: (2022)

Impact of conventional lipid-lowering therapy on circulating levels of PCSK9: protocol for a systematic review and meta-analysis of randomised controlled trials
por: Luo, Jichang, et al.
Publicado: (2022)

Development and Validation of a Nomogram of In-hospital Major Adverse Cardiovascular and Cerebrovascular Events in Patients With Acute Coronary Syndrome
por: Bo, Xiangwei, et al.
Publicado: (2021)

Relation Between Plasma Proteomics Analysis and Major Adverse Cardiovascular Events in Patients With Stable Coronary Artery Disease
por: Dregoesc, Mihaela Ioana, et al.
Publicado: (2022)

Randomised controlled trial to investigate optimal antithrombotic therapy in patients with non-valvular atrial fibrillation undergoing percutaneous coronary intervention: a study protocol of the OPTIMA-AF trial
por: Sotomi, Yohei, et al.
Publicado: (2021)

Systemic inflammatory response index over neutrophil–lymphocyte ratio and monocyte–lymphocyte ratio: comparison of prognostic performance in predicting major adverse cardiac events: [Regarding: Prognostic value of systemic inflammatory response index in patients with acute coronary syndrome undergoing percutaneous coronary intervention]
por: Mangalesh, Sridhar, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t8m4pip93p5eeu14avt8lpi51r